AP2733A - Quinoline derivatives as antibacterial agents - Google Patents
Quinoline derivatives as antibacterial agentsInfo
- Publication number
- AP2733A AP2733A AP2008004300A AP2008004300A AP2733A AP 2733 A AP2733 A AP 2733A AP 2008004300 A AP2008004300 A AP 2008004300A AP 2008004300 A AP2008004300 A AP 2008004300A AP 2733 A AP2733 A AP 2733A
- Authority
- AP
- ARIPO
- Prior art keywords
- antibacterial agents
- quinoline derivatives
- quinoline
- derivatives
- antibacterial
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05105769 | 2005-06-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2733A true AP2733A (en) | 2013-09-30 |
Family
ID=35445742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2008004300A AP2733A (en) | 2005-06-28 | 2006-06-26 | Quinoline derivatives as antibacterial agents |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US20100204270A1 (xx) |
| EP (1) | EP1898910B1 (xx) |
| JP (1) | JP5193859B2 (xx) |
| KR (1) | KR101423229B1 (xx) |
| CN (1) | CN101252928B (xx) |
| AP (1) | AP2733A (xx) |
| AR (1) | AR057654A1 (xx) |
| AU (1) | AU2006263884B2 (xx) |
| BR (1) | BRPI0612534B8 (xx) |
| CA (1) | CA2612623C (xx) |
| CY (1) | CY1118515T1 (xx) |
| DK (1) | DK1898910T3 (xx) |
| EA (1) | EA014163B1 (xx) |
| ES (1) | ES2606772T3 (xx) |
| HK (1) | HK1120734A1 (xx) |
| HR (1) | HRP20161704T1 (xx) |
| HU (1) | HUE031268T2 (xx) |
| IL (1) | IL188394A (xx) |
| JO (1) | JO3270B1 (xx) |
| LT (1) | LT1898910T (xx) |
| ME (1) | ME02690B (xx) |
| MX (1) | MX2008000082A (xx) |
| MY (1) | MY151030A (xx) |
| NO (1) | NO341283B1 (xx) |
| NZ (1) | NZ564339A (xx) |
| PL (1) | PL1898910T3 (xx) |
| PT (1) | PT1898910T (xx) |
| RS (1) | RS55408B1 (xx) |
| SG (1) | SG166799A1 (xx) |
| SI (1) | SI1898910T1 (xx) |
| TW (1) | TWI392494B (xx) |
| UA (1) | UA91549C2 (xx) |
| WO (1) | WO2007000436A1 (xx) |
| ZA (1) | ZA200711149B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9790186B2 (en) | 2009-07-21 | 2017-10-17 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
| PL2841425T3 (pl) | 2012-04-27 | 2016-10-31 | Antybakteryjne pochodne chinoliny | |
| IN2014MN02358A (xx) | 2012-04-27 | 2015-08-14 | Janssen Pharmaceutica Nv | |
| CN105037497B (zh) * | 2015-03-27 | 2018-06-26 | 中牧实业股份有限公司 | 一种恩拉霉素的提纯方法 |
| WO2017035288A1 (en) * | 2015-08-27 | 2017-03-02 | Trustees Of Dartmouth College | Composition and method for prevention, mitigation or treatment of an enteropathogenic bacterial infection |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004011436A1 (en) * | 2002-07-25 | 2004-02-05 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| DE19937116A1 (de) * | 1999-08-06 | 2001-02-08 | Bayer Ag | Moxifloxacin Kochsalzformulierung |
| WO2005117875A1 (en) * | 2004-05-28 | 2005-12-15 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
| EE05394B1 (et) * | 2004-12-24 | 2011-04-15 | Janssen Pharmaceutica N.V. | Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis |
-
2006
- 2006-06-25 JO JOP/2006/0189A patent/JO3270B1/ar active
- 2006-06-26 AP AP2008004300A patent/AP2733A/xx active
- 2006-06-26 EP EP06763891.6A patent/EP1898910B1/en active Active
- 2006-06-26 BR BRPI0612534A patent/BRPI0612534B8/pt not_active IP Right Cessation
- 2006-06-26 PL PL06763891T patent/PL1898910T3/pl unknown
- 2006-06-26 AU AU2006263884A patent/AU2006263884B2/en active Active
- 2006-06-26 SI SI200632126A patent/SI1898910T1/sl unknown
- 2006-06-26 ME MEP-2016-291A patent/ME02690B/me unknown
- 2006-06-26 LT LTEP06763891.6T patent/LT1898910T/lt unknown
- 2006-06-26 MX MX2008000082A patent/MX2008000082A/es active IP Right Grant
- 2006-06-26 US US11/917,923 patent/US20100204270A1/en not_active Abandoned
- 2006-06-26 JP JP2008518812A patent/JP5193859B2/ja active Active
- 2006-06-26 UA UAA200714716A patent/UA91549C2/ru unknown
- 2006-06-26 DK DK06763891.6T patent/DK1898910T3/en active
- 2006-06-26 CN CN2006800313527A patent/CN101252928B/zh active Active
- 2006-06-26 PT PT67638916T patent/PT1898910T/pt unknown
- 2006-06-26 EA EA200800152A patent/EA014163B1/ru unknown
- 2006-06-26 CA CA2612623A patent/CA2612623C/en active Active
- 2006-06-26 ES ES06763891.6T patent/ES2606772T3/es active Active
- 2006-06-26 WO PCT/EP2006/063556 patent/WO2007000436A1/en active Application Filing
- 2006-06-26 SG SG201007977-0A patent/SG166799A1/en unknown
- 2006-06-26 KR KR1020087002248A patent/KR101423229B1/ko active IP Right Grant
- 2006-06-26 RS RS20161121A patent/RS55408B1/sr unknown
- 2006-06-26 HU HUE06763891A patent/HUE031268T2/en unknown
- 2006-06-26 NZ NZ564339A patent/NZ564339A/en unknown
- 2006-06-27 MY MYPI20063045 patent/MY151030A/en unknown
- 2006-06-27 AR ARP060102760A patent/AR057654A1/es unknown
- 2006-06-27 TW TW095123051A patent/TWI392494B/zh active
-
2007
- 2007-12-20 ZA ZA200711149A patent/ZA200711149B/xx unknown
- 2007-12-25 IL IL188394A patent/IL188394A/en active IP Right Grant
-
2008
- 2008-01-25 NO NO20080481A patent/NO341283B1/no not_active IP Right Cessation
- 2008-11-18 HK HK08112595.6A patent/HK1120734A1/xx unknown
-
2012
- 2012-08-07 US US13/568,597 patent/US20130030017A1/en not_active Abandoned
-
2016
- 2016-12-13 HR HRP20161704TT patent/HRP20161704T1/hr unknown
- 2016-12-20 CY CY20161101322T patent/CY1118515T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004011436A1 (en) * | 2002-07-25 | 2004-02-05 | Janssen Pharmaceutica N.V. | Quinoline derivatives and their use as mycobacterial inhibitors |
Non-Patent Citations (3)
| Title |
|---|
| ANDRIES, KOEN ET AL.: SCIENCE, vol. 307, 14 January 2005 (2005-01-14), pages 223-227, XP002358962, cited in the application, p. 223-224 * |
| DESAI P.K. ET AL.: "QUINOLINE DERIVATIVES AS ANTITUBERCULAR/ANTIBACTERIAL AGENTS", INDIAN JOURNAL OF CHEMISTRY, JODHPUR, IN, vol. 35B, no. 8, August 1996 (1996-08), p. 871-873, XP000944820, the whole document * |
| HELWIG, BURGHARD: "Moderne Arzneimittel", 1980, WISSENSCHAFTLICHE VERLAGSGESELLSCHAFT, STUTTGART, XP002359316, page 395 * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP2654A (en) | Quinoline derivatives as antibacterial agents | |
| ZA200801108B (en) | Quinoline derivatives as antibacterial agents | |
| IL187904A0 (en) | Quinoline derivatives as antibacterial agents | |
| HK1120732A1 (en) | Quinoline derivatives as antibacterial agents | |
| HK1124232A1 (en) | Quinoline derivatives as antibacterial agents | |
| HK1122730A1 (en) | Quinoline derivatives as antibacterial agents | |
| HK1120734A1 (en) | Quinoline derivatives as antibacterial agents | |
| ZA200710698B (en) | Quinoline derivatives as antibacterial agents |